Morphological and genetic heterogeneity of synchronous multifocal lung adenocarcinoma in a Chinese cohort

BMC Cancer

Table 1 Clinicopathologic characteristics of patients with SMLC

Case	Sex	Age	Tumor	Site	Size (cm)	LM	Type	Subtype(%)					Histologic type
Case	Sex	Age	Tumor	Site	Size (cm)	LM	Type	L	A	P	M	S	Histologic type
1	F	62	01	LUL	2.5	N	AP	0	100	0	0	0
1	F	62	02	RUL	3.5		ASC	N/A	N/A	N/A	N/A	N/A
2	F	51	01	RLL	0.6	N	AIS	100	0	0	0	0
2	F	51	02	RLL	0.4		AIS	100	0	0	0	0
3	F	55	01	RUL	0.4	N	AIS	100	0	0	0	0
3	F	55	02	RML	0.8		LP	80	20	0	0	0
4	F	43	01	RLL	0.3	N	AIS	100	0	0	0	0
			02	RML	0.7		LP	60	40	0	0	0
			03	LUL	0.5		AIS	100	0	0	0	0
			04	LLL	0.4		AIS	100	0	0	0	0
5	F	51	01	RML	0.6	N	AIS	100	0	0	0	0
			02	RLL	0.5		LP	70	30	0	0	0
			03	RLL	0.4		AIS	100	0	0	0	0
6	F	75	01	RLL	1.5	N	AP	20	80	0	0	0
6	F	75	02	RUL	1.7		AP	0	70	20	10	0
7	F	47	01	RLL	1.3	N	AP	0	100	0	0	0
7	F	47	02	RUL	0.5		AIS	100	0	0	0	0
8	M	74	01	RUL	4	N	AP	0	50	0	0	50
8	M	74	02	RLL	0.7		MA	N/A	N/A	N/A	N/A	N/A
9	F	32	01	RLL	0.8	N	AP	0	100	0	0	0
9	F	32	02	RLL	0.5		AIS	100	0	0	0	0
10	M	78	01	RUL	2.0	N	SP	0	0	0	0	100
10	M	78	02	RUL	1.4		AIS	100	0	0	0	0
11	M	67	01	RLL	0.9	N	AIS	100	0	0	0	0
11	M	67	02	RLL	0.8		LP	60	20	20	0	0
12	F	61	01	RUL	1.2	N	AP	40	60	0	0	0
			02	RUL	0.9		LP	80	20	0	0	0
			03	RUL	0.9		AIS	100	0	0	0	0
13	M	65	01	LUL	1.2	N	LP	40	40	10	10	0
			02	LUL	1.1		LP	80	15	5	0	0
			03	RUL	0.5		AIS	100	0	0	0	0
			04	RLL	2.0		PP	20	30	40	10	0
14	M	87	01	LLL	1	N	AP	20	50	0	0	30
14	M	87	02	LLL	1.3		AP	0	90	0	0	10
15	M	50	01	LUL	0.5	N	AP	0	100	0	0	0
15	M	50	02	LUL	2.0		LP	55	45	0	0	0
16	M	71	01	RUL	2	N	AP	0	60	20	0	20
			02	RUL	0.8		AIS	100	0	0	0	0
			03	RUL	0.5		AIS	100	0	0	0	0
			04	RUL	0.8		AP	0	100	0	0	0
17	M	63	01	RML	1.2	N	LP	70	30	0	0	0
17	M	63	02	RML	1		SP	0	20	0	0	80
18	M	54	01	RML	1	Y	SP	0	30	30	0	40
18	M	54	02	RLL	0.4		LP	90	10	0	0	0
19	F	65	01	RUL	1.2	Y	AP	0	60	40	0	0
19	F	65	02	RLL	1.1		AIS	100	0	0	0	0
20	F	60	01	RLL	2.5	Y	AP	30	70	0	0	0
20	F	60	02	RUL	4		SP	0	40	0	0	60
21	M	63	01	RLL	1.0	Y	SP	0	10	10	0	80
21	M	63	02	RML	0.5		AP	20	80	0	0	0

Abbreviations: A acinar, AIS adenocarcinoma in situ, AP acinar predominant, ASC adenosquamous carcinoma, F female, L lepidic, LLL left lower lobe, LM Lymph node metastasis, LP lepidic predominant, LUL left upper lobe, M male, M micropapillary, MA mucinous adenocarcinoma, N none, P papillary, PP papillary predominant, RLL right lower lobe, RML right middle lobe, RUL right upper lobe, S solid, SP solid predominant, Y yes

ISSN: 1471-2407